Position in VRTX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$12,652,209
+$733,610 QoQ
Shares Held
25,471
-4.6% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#328
of 1,735 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ASR Vermogensbeheer N.V. holds $37,601,819 across 6 Biotechnology names. VRTX ranks #1 (33.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
25,471 | $12,652,209 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,098 | $9,414,206 | |
| 3 | RPRX |
Royalty Pharma plc
|
122,222 | $6,852,987 | |
| 4 | INCY |
Incyte Corp
|
57,499 | $6,518,086 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,375 | $1,618,036 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,917 | $546,295 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,652,209 | 25,471 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $11,918,599 | 26,691 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $11,814,108 | 26,059 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $10,297,782 | 26,294 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $11,761,738 | 26,419 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $12,858,396 | 26,522 | Shares | Defined | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||